Tempus AI is trading at $81.76, up 7.51%, alongside a broad market advance; no clear company-specific announcement explaining the November 9 move was identified.
- The S&P 500 was up 1.68%, Nasdaq 2.13%, and Dow 1.37%.
- An expansion of Tempus AI’s collaboration with Remix Therapeutics was reported November 8, but coverage does not establish it as the direct cause.
- Trading volume and activity details were unavailable in the reviewed sources.